ArticleCancer medicine2020

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.

Antonio Cuneo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.